{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T11:10:16Z","timestamp":1769598616187,"version":"3.49.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,28]]},"DOI":"10.7759\/cureus.72522","type":"journal-article","created":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T09:31:23Z","timestamp":1730107883000},"source":"Crossref","is-referenced-by-count":2,"title":["Clinical Characteristics and Management of Drug-Induced Lupus Caused by Tumor Necrosis Factor Inhibitors: A Comprehensive Review"],"prefix":"10.7759","author":[{"given":"Seyedehtina","family":"Safaei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Kimiaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malik","family":"Kasapoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fulya","family":"Co\u015fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Drug-induced lupus erythematosus","author":"Solhjoo M","year":"2023","unstructured":"Solhjoo M, Goyal A, Chauhan K. Drug-induced lupus erythematosus. StatPearls. StatPearls Publishing, Treasure Island, FL; 2023."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198806023182209","article-title":"Drug-related lupus","volume":"318","author":"Hess E","year":"1988","unstructured":"Hess E. Drug-related lupus. N Engl J Med. 1988, 318:1460-2. 10.1056\/NEJM198806023182209","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-008-0895-5","article-title":"Drug-induced lupus erythematosus","volume":"301","author":"Vedove CD","year":"2009","unstructured":"Vedove CD, Del Giglio M, Schena D, Girolomoni G. Drug-induced lupus erythematosus. Arch Dermatol Res. 2009, 301:99-105. 10.1007\/s00403-008-0895-5","journal-title":"Arch Dermatol Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.34489","article-title":"Lupus cardiomyopathy and nephritis associated with adalimumab and cytomegalovirus infection in a patient with seronegative rheumatoid arthritis: a case of Rhupus syndrome","volume":"15","author":"Waitayangkoon P","year":"2023","unstructured":"Waitayangkoon P, Chen L, Liu JB, Weins A, Barbosa F, Treadwell T. Lupus cardiomyopathy and nephritis associated with adalimumab and cytomegalovirus infection in a patient with seronegative rheumatoid arthritis: a case of Rhupus syndrome. Cureus. 2023, 15:e34489. 10.7759\/cureus.34489","journal-title":"Cureus"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-021-06781-x","article-title":"Infliximab-induced lupus causing pericarditis: a case report and review of the literature","volume":"36","author":"Thiriveedi M","year":"2021","unstructured":"Thiriveedi M, Steuber TD, Hasan M, Baggett A. Infliximab-induced lupus causing pericarditis: a case report and review of the literature. J Gen Intern Med. 2021, 36:2134-8. 10.1007\/s11606-021-06781-x","journal-title":"J Gen Intern Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1177\/03000605211022510","article-title":"Severe lupus induced by the tumor necrosis factor-alpha inhibitor Anbainuo: a case report","volume":"49","author":"Pan X","year":"2021","unstructured":"Pan X, Yuan Y, Huang F, Tian M. Severe lupus induced by the tumor necrosis factor-alpha inhibitor Anbainuo: a case report. J Int Med Res. 2021, 49:3000605211022510. 10.1177\/03000605211022510","journal-title":"J Int Med Res"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4103\/meajo.MEAJO_238_19","article-title":"Vogt-Koyanagi-Harada disease and systemic lupus erythematosus occurring during adalimumab therapy for ulcerative colitis","volume":"27","author":"AlBloushi AF","year":"2020","unstructured":"AlBloushi AF, Al-Hadlaq OS, AlRashed FA, Abu El-Asrar AM. Vogt-Koyanagi-Harada disease and systemic lupus erythematosus occurring during adalimumab therapy for ulcerative colitis. Middle East Afr J Ophthalmol. 2020, 27:185-7. 10.4103\/meajo.MEAJO_238_19","journal-title":"Middle East Afr J Ophthalmol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.4646-20","article-title":"Drug-induced bullous pemphigoid and lupus erythematosus occurring under anti-TNF-\u03b1 and IL-6 therapy in a patient with rheumatoid arthritis","volume":"59","author":"Yoshikawa N","year":"2020","unstructured":"Yoshikawa N, Matsubara E, Yamamoto M, Yamazaki H, Uehara M, Kamata M, Tanaka H. Drug-induced bullous pemphigoid and lupus erythematosus occurring under anti-TNF-\u03b1 and IL-6 therapy in a patient with rheumatoid arthritis. Intern Med. 2020, 59:2611-8. 10.2169\/internalmedicine.4646-20","journal-title":"Intern Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.01.017","article-title":"Anti-TNF rechallenge after infliximab induced lupus in Crohn\u2019s disease","volume":"158","author":"Loebenstein M","year":"2020","unstructured":"Loebenstein M, Schulberg JD. Anti-TNF rechallenge after infliximab induced lupus in Crohn\u2019s disease. Gastroenterology. 2020, 158:2069-71. 10.1053\/j.gastro.2020.01.017","journal-title":"Gastroenterology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.14674","article-title":"Anti-tumor necrosis factor (TNF)-induced lupus in a patient with hidradenitis suppurativa","volume":"59","author":"Turk D","year":"2020","unstructured":"Turk D, Vellaichamy G, Lyons AB, Parks-Miller A, Nelson T, Meysami A, Hamzavi IH. Anti-tumor necrosis factor (TNF)-induced lupus in a patient with hidradenitis suppurativa. Int J Dermatol. 2020, 59:e73-4. 10.1111\/ijd.14674","journal-title":"Int J Dermatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2017-223473","article-title":"Anti-TNF therapy-induced lupus erythematosus-like syndrome in a patient treated with adalimumab for cutaneous psoriasis","volume":"2018","author":"Stein JE","year":"2018","unstructured":"Stein JE, Patterson-Fortin J, Bodnar BE. Anti-TNF therapy-induced lupus erythematosus-like syndrome in a patient treated with adalimumab for cutaneous psoriasis. BMJ Case Rep. 2018, 2018:bcr2017223473. 10.1136\/bcr-2017-223473","journal-title":"BMJ Case Rep"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12506","article-title":"A case of lupus-like syndrome in a patient receiving adalimumab and a brief review of the literature on drug-induced lupus erythematosus","volume":"42","author":"Lomicov\u00e1 I","year":"2017","unstructured":"Lomicov\u00e1 I, Such\u00fd D, Pizinger K, Cetkovsk\u00e1 P. A case of lupus-like syndrome in a patient receiving adalimumab and a brief review of the literature on drug-induced lupus erythematosus. J Clin Pharm Ther. 2017, 42:363-6. 10.1111\/jcpt.12506","journal-title":"J Clin Pharm Ther"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1177\/0961203316662724","article-title":"Rapidly progressive lupus nephritis associated with golimumab in a patient with systemic lupus erythematosus and rheumatoid arthritis","volume":"26","author":"Saka Y","year":"2017","unstructured":"Saka Y, Taniguchi Y, Nagahara Y, Yamashita R, Karasawa M, Naruse T, Watanabe Y. Rapidly progressive lupus nephritis associated with golimumab in a patient with systemic lupus erythematosus and rheumatoid arthritis. Lupus. 2017, 26:447-8. 10.1177\/0961203316662724","journal-title":"Lupus"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.2017.1249266","article-title":"TNF-alpha antagonist induced lupus on three different agents","volume":"129","author":"Mudduluru BM","year":"2017","unstructured":"Mudduluru BM, Shah S, Shamah S, Swaminath A. TNF-alpha antagonist induced lupus on three different agents. Postgrad Med. 2017, 129:304-6. 10.1080\/00325481.2017.1249266","journal-title":"Postgrad Med"},{"key":"ref15","article-title":"Annular elastolytic giant cell granuloma successfully treated with adalimumab subsequently complicated by drug-induced lupus","volume":"16","author":"Haimovic A","year":"2017","unstructured":"Haimovic A, Kamino H, Cohen DE. Annular elastolytic giant cell granuloma successfully treated with adalimumab subsequently complicated by drug-induced lupus. J Drugs Dermatol. 2017, 16:169-71.","journal-title":"J Drugs Dermatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-012-2617-8","article-title":"A patient with ankylosing spondylitis who developed infliximab-induced lupus and treated with etanercept","volume":"34","author":"Akg\u00fcl \u00d6","year":"2014","unstructured":"Akg\u00fcl \u00d6, K\u0131l\u0131\u00e7 G, K\u0131l\u0131\u00e7 E, C\u00fcce \u0130, \u00d6zg\u00f6\u00e7men S. A patient with ankylosing spondylitis who developed infliximab-induced lupus and treated with etanercept. Rheumatol Int. 2014, 34:443-4. 10.1007\/s00296-012-2617-8","journal-title":"Rheumatol Int"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2013.11.011","article-title":"Drug-induced lupus erythematosus presenting with cardiac tamponade: a case report and literature review","volume":"30","author":"Harnett DT","year":"2014","unstructured":"Harnett DT, Chandra-Sekhar HB, Hamilton SF. Drug-induced lupus erythematosus presenting with cardiac tamponade: a case report and literature review. Can J Cardiol. 2014, 30:247.e11-2. 10.1016\/j.cjca.2013.11.011","journal-title":"Can J Cardiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.12054","article-title":"Drug-induced lupus and autoimmune hepatitis secondary to infliximab for psoriasis","volume":"55","author":"Dang LJ","year":"2014","unstructured":"Dang LJ, Lubel JS, Gunatheesan S, Hosking P, Su J. Drug-induced lupus and autoimmune hepatitis secondary to infliximab for psoriasis. Australas J Dermatol. 2014, 55:75-9. 10.1111\/ajd.12054","journal-title":"Australas J Dermatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-013-2361-9","article-title":"A case of infliximab-induced lupus in a patient with ankylosing spondylitis: is it safe switch to another anti-TNF-\u03b1 agent?","volume":"32","author":"Santiago T","year":"2013","unstructured":"Santiago T, Santiago MG, Rovisco J, Duarte C, Malcata A, da Silva JA. A case of infliximab-induced lupus in a patient with ankylosing spondylitis: is it safe switch to another anti-TNF-\u03b1 agent?. Clin Rheumatol. 2013, 32:1819-22. 10.1007\/s10067-013-2361-9","journal-title":"Clin Rheumatol"},{"key":"ref20","article-title":"Spontaneous resolution of lupus nephritis following withdrawal of etanercept","volume":"43","author":"Yahya TM","year":"2013","unstructured":"Yahya TM, Dhanyamraju S, Harrington TM, Prichard JW. Spontaneous resolution of lupus nephritis following withdrawal of etanercept. Ann Clin Lab Sci. 2013, 43:447-9.","journal-title":"Ann Clin Lab Sci"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2012.06.016","article-title":"Anti-tumor necrosis factor-\u03b1 induced systemic lupus erythematosus in a patient with metastatic Crohn's disease--what is the role of anti-TNF antibody?","volume":"7","author":"Farkas K","year":"2013","unstructured":"Farkas K, Nagy F, Kov\u00e1cs L, Wittmann T, Moln\u00e1r T. Anti-tumor necrosis factor-\u03b1 induced systemic lupus erythematosus in a patient with metastatic Crohn's disease--what is the role of anti-TNF antibody?. J Crohns Colitis. 2013, 7:e143-5. 10.1016\/j.crohns.2012.06.016","journal-title":"J Crohns Colitis"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2012.09.034","article-title":"Induction of severe systemic lupus erythematosus by TNF blockade and response to anti-IL-6 strategy","volume":"131","author":"Adler S","year":"2013","unstructured":"Adler S, Kolev M, Varisco PA, Tham M, von Gunten M, Tappeiner C, Villiger PM. Induction of severe systemic lupus erythematosus by TNF blockade and response to anti-IL-6 strategy. J Allergy Clin Immunol. 2013, 131:1235-7. 10.1016\/j.jaci.2012.09.034","journal-title":"J Allergy Clin Immunol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-011-2016-6","article-title":"Lupus attributable to anti-TNF therapy and revealed by interstitial granulomatous dermatitis","volume":"32","author":"Guerin M","year":"2012","unstructured":"Guerin M, Haettich B, Bara C, Artru L, Prophette B, C\u00e9l\u00e9rier P, Maillard H. Lupus attributable to anti-TNF therapy and revealed by interstitial granulomatous dermatitis. Rheumatol Int. 2012, 32:2937-40. 10.1007\/s00296-011-2016-6","journal-title":"Rheumatol Int"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2011.04.017","article-title":"A lupus-like syndrome induced by infliximab treatment","volume":"35","author":"Liggi M","year":"2011","unstructured":"Liggi M, Gilli A, Lai MA, Francesca Boi M, Usai P. A lupus-like syndrome induced by infliximab treatment. Clin Res Hepatol Gastroenterol. 2011, 35:685-7. 10.1016\/j.clinre.2011.04.017","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"ref25","article-title":"Adalimumab-induced lupus erythematosus with central nervous system involvement in a patient with Crohn's disease","volume":"20","author":"Vannucchi V","year":"2011","unstructured":"Vannucchi V, Grazzini M, Pieralli F, Giannotta M, Biagioni C, Nozzoli C. Adalimumab-induced lupus erythematosus with central nervous system involvement in a patient with Crohn's disease. J Gastrointestin Liver Dis. 2011, 20:201-3.","journal-title":"J Gastrointestin Liver Dis"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.100830","article-title":"Successful switch of patients with rheumatoid arthritis developing anti-tumor necrosis factor (anti-TNF)-induced lupus to another anti-TNF agent","volume":"38","author":"Ye C","year":"2011","unstructured":"Ye C, Sholter D, Martin L, Keeling S. Successful switch of patients with rheumatoid arthritis developing anti-tumor necrosis factor (anti-TNF)-induced lupus to another anti-TNF agent. J Rheumatol. 2011, 38:1216; author reply 1217-8. 10.3899\/jrheum.100830","journal-title":"J Rheumatol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.101020","article-title":"Role of anti-tumor necrosis factor-alpha blockers in inducing lupus erythematosus tumidus in \u201cRhupus syndrome\u201d","volume":"38","author":"Chogle AR","year":"2011","unstructured":"Chogle AR, Shah CV, Murthy AK. Role of anti-tumor necrosis factor-alpha blockers in inducing lupus erythematosus tumidus in \u201cRhupus syndrome\u201d. J Rheumatol. 2011, 38:1218-9. 10.3899\/jrheum.101020","journal-title":"J Rheumatol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2011.04871.x","article-title":"TNF alpha antagonist-induced lupus-like syndrome: report and review of the literature with implications for treatment with alternative TNF alpha antagonists","volume":"50","author":"Williams VL","year":"2011","unstructured":"Williams VL, Cohen PR. TNF alpha antagonist-induced lupus-like syndrome: report and review of the literature with implications for treatment with alternative TNF alpha antagonists. Int J Dermatol. 2011, 50:619-25. 10.1111\/j.1365-4632.2011.04871.x","journal-title":"Int J Dermatol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2010.02.033","article-title":"Is the family history positive for SLE a predisposing factor for anti-TNFalpha blockers induced lupus? A case report","volume":"77","author":"Caramaschi P","year":"2010","unstructured":"Caramaschi P, Ravagnani V, Bambara LM, Biasi D. Is the family history positive for SLE a predisposing factor for anti-TNFalpha blockers induced lupus? A case report. Joint Bone Spine. 2010, 77:484-5. 10.1016\/j.jbspin.2010.02.033","journal-title":"Joint Bone Spine"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-009-1365-y","article-title":"Tumour necrosis factor inhibitor-related lupus: safety of switching agents","volume":"29","author":"Luong JM","year":"2010","unstructured":"Luong JM, Tan BT, Buchanan RR, Schachna L. Tumour necrosis factor inhibitor-related lupus: safety of switching agents. Clin Rheumatol. 2010, 29:551-3. 10.1007\/s10067-009-1365-y","journal-title":"Clin Rheumatol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0b013e3181837289","article-title":"Drug-induced lupus associated with infliximab and adalimumab in an adolescent with Crohn disease","volume":"49","author":"Zella GC","year":"2009","unstructured":"Zella GC, Weinblatt ME, Winter HS. Drug-induced lupus associated with infliximab and adalimumab in an adolescent with Crohn disease. J Pediatr Gastroenterol Nutr. 2009, 49:355-8. 10.1097\/MPG.0b013e3181837289","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1177\/0961203308100560","article-title":"Etanercept-associated SLE with lupus nephritis","volume":"18","author":"Neradov\u00e1 A","year":"2009","unstructured":"Neradov\u00e1 A, Stam F, van den Berg JG, Bax WA. Etanercept-associated SLE with lupus nephritis. Lupus. 2009, 18:667-8. 10.1177\/0961203308100560","journal-title":"Lupus"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1177\/0961203308093922","article-title":"Is the development of drug-related lupus a contraindication for switching from one TNF alpha inhibitor to another?","volume":"18","author":"Kocharla L","year":"2009","unstructured":"Kocharla L, Mongey AB. Is the development of drug-related lupus a contraindication for switching from one TNF alpha inhibitor to another?. Lupus. 2009, 18:169-71. 10.1177\/0961203308093922","journal-title":"Lupus"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-008-0684-7","article-title":"Infliximab-induced lupus-like syndrome in a patient with ankylosing spondylitis","volume":"29","author":"Bodur H","year":"2009","unstructured":"Bodur H, Eser F, Konca S, Arikan S. Infliximab-induced lupus-like syndrome in a patient with ankylosing spondylitis. Rheumatol Int. 2009, 29:451-4. 10.1007\/s00296-008-0684-7","journal-title":"Rheumatol Int"},{"key":"ref35","article-title":"Drug-induced lupus-like syndrome in ankylosing spondylitis treated with infliximab","volume":"26","author":"Mounach A","year":"2008","unstructured":"Mounach A, Ghazi M, Nouijai A, Ghozlani I, Achemlal L, Bezza A, El Maghraoui A. Drug-induced lupus-like syndrome in ankylosing spondylitis treated with infliximab. Clin Exp Rheumatol. 2008, 26:1116-8.","journal-title":"Clin Exp Rheumatol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-0034","article-title":"Etanercept-induced lupus erythematosus presenting as a unilateral pleural effusion","volume":"134","author":"Abunasser J","year":"2008","unstructured":"Abunasser J, Forouhar FA, Metersky ML. Etanercept-induced lupus erythematosus presenting as a unilateral pleural effusion. Chest. 2008, 134:850-3. 10.1378\/chest.08-0034","journal-title":"Chest"},{"key":"ref37","article-title":"Development of systemic lupus erythematosus in a patient with rheumatoid arthritis following treatment conversion of infliximab to adalimumab","volume":"7","author":"Havel J","year":"2008","unstructured":"Havel J, Aboutalebi S, Doughty L, Wirges M. Development of systemic lupus erythematosus in a patient with rheumatoid arthritis following treatment conversion of infliximab to adalimumab. J Drugs Dermatol. 2008, 7:796-8.","journal-title":"J Drugs Dermatol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1177\/0961203307088291","article-title":"Adalimumab-induced lupus erythematosus","volume":"17","author":"Mart\u00edn JM","year":"2008","unstructured":"Mart\u00edn JM, Ricart JM, Alc\u00e1cer J, Rausell N, Arana G. Adalimumab-induced lupus erythematosus. Lupus. 2008, 17:676-8. 10.1177\/0961203307088291","journal-title":"Lupus"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2008.03.102","article-title":"Tumor necrosis factor-alpha inhibitor-induced lupus-like syndrome presenting as fever of unknown origin in a liver transplant recipient: case report and concise review of the literature","volume":"40","author":"Page AV","year":"2008","unstructured":"Page AV, Liles WC. Tumor necrosis factor-alpha inhibitor-induced lupus-like syndrome presenting as fever of unknown origin in a liver transplant recipient: case report and concise review of the literature. Transplant Proc. 2008, 40:1768-70. 10.1016\/j.transproceed.2008.03.102","journal-title":"Transplant Proc"},{"key":"ref40","article-title":"Adalimumab-induced lupus erythematosus in Crohn's disease patients previously treated with infliximab","volume":"57","author":"Ma\u00f1osa M","year":"2008","unstructured":"Ma\u00f1osa M, Dom\u00e8nech E, Mar\u00edn L, Oliv\u00e9 A, Zabana Y, Cabr\u00e9 E, Gassull MA. Adalimumab-induced lupus erythematosus in Crohn's disease patients previously treated with infliximab. Gut. 2008, 57:559-60.","journal-title":"Gut"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2006.21.5.946","article-title":"Etanercept-induced systemic lupus erythematosus in a patient with rheumatoid arthritis","volume":"21","author":"Kang MJ","year":"2006","unstructured":"Kang MJ, Lee YH, Lee J. Etanercept-induced systemic lupus erythematosus in a patient with rheumatoid arthritis. J Korean Med Sci. 2006, 21:946-9. 10.3346\/jkms.2006.21.5.946","journal-title":"J Korean Med Sci"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kel227","article-title":"Onset of systemic lupus erythematosus after conversion of infliximab to adalimumab treatment in rheumatoid arthritis with a pre-existing anti-dsDNA antibody level","volume":"45","author":"van Rijthoven AW","year":"2006","unstructured":"van Rijthoven AW, Bijlsma JW, Canninga-van Dijk M, Derksen RH, van Roon JA. Onset of systemic lupus erythematosus after conversion of infliximab to adalimumab treatment in rheumatoid arthritis with a pre-existing anti-dsDNA antibody level. Rheumatology (Oxford). 2006, 45:1317-9. 10.1093\/rheumatology\/kel227","journal-title":"Rheumatology (Oxford)"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1002\/art.21702","article-title":"Infliximab-related lupus and associated valvulitis: a case report and review of the literature","volume":"55","author":"Chadha T","year":"2006","unstructured":"Chadha T, Hernandez JE. Infliximab-related lupus and associated valvulitis: a case report and review of the literature. Arthritis Rheum. 2006, 55:163-6. 10.1002\/art.21702","journal-title":"Arthritis Rheum"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kei220","article-title":"Drug-induced systemic lupus erythematosus in ankylosing spondylitis associated with infliximab","volume":"45","author":"P\u00e9rez-Garc\u00eda C","year":"2006","unstructured":"P\u00e9rez-Garc\u00eda C, Maymo J, Lisbona P\u00e9rez MP, Almirall Bernab\u00e9 M, Carbonell Abell\u00f3 J. Drug-induced systemic lupus erythematosus in ankylosing spondylitis associated with infliximab. Rheumatology (Oxford). 2006, 45:114-6. 10.1093\/rheumatology\/kei220","journal-title":"Rheumatology (Oxford)"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kei227","article-title":"Infliximab-induced lupus-like reaction in a patient with psoriatic arthritis","volume":"45","author":"Pallotta P","year":"2006","unstructured":"Pallotta P, Cianchini G, Ruffelli M, Puddu P. Infliximab-induced lupus-like reaction in a patient with psoriatic arthritis. Rheumatology (Oxford). 2006, 45:116-7. 10.1093\/rheumatology\/kei227","journal-title":"Rheumatology (Oxford)"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1097\/01.rhu.0000152148.55133.ba","article-title":"Drug-induced lupus after treatment with infliximab in rheumatoid arthritis","volume":"11","author":"Benucci M","year":"2005","unstructured":"Benucci M, Li Gobbi F, Fossi F, Manfredi M, Del Rosso A. Drug-induced lupus after treatment with infliximab in rheumatoid arthritis. J Clin Rheumatol. 2005, 11:47-9. 10.1097\/01.rhu.0000152148.55133.ba","journal-title":"J Clin Rheumatol"},{"key":"ref47","article-title":"Tumor necrosis factor-alpha antagonists induce lupus-like syndrome in patients with scleroderma overlap\/mixed connective tissue disease","volume":"30","author":"Christopher-Stine L","year":"2003","unstructured":"Christopher-Stine L, Wigley F. Tumor necrosis factor-alpha antagonists induce lupus-like syndrome in patients with scleroderma overlap\/mixed connective tissue disease. J Rheumatol. 2003, 30:2725-7.","journal-title":"J Rheumatol"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/s1590-8658(03)00448-1","article-title":"Infliximab-induced lupus in Crohn's disease: a case report","volume":"35","author":"Sarzi-Puttini P","year":"2003","unstructured":"Sarzi-Puttini P, Ardizzone S, Manzionna G, et al.. Infliximab-induced lupus in Crohn's disease: a case report. Dig Liver Dis. 2003, 35:814-7. 10.1016\/s1590-8658(03)00448-1","journal-title":"Dig Liver Dis"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-002-0654-5","article-title":"Anti-TNF-alpha-induced systemic lupus syndrome","volume":"22","author":"Debandt M","year":"2003","unstructured":"Debandt M, Vittecoq O, Descamps V, Le Lo\u00ebt X, Meyer O. Anti-TNF-alpha-induced systemic lupus syndrome. Clin Rheumatol. 2003, 22:56-61. 10.1007\/s10067-002-0654-5","journal-title":"Clin Rheumatol"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-137-7-200210010-00030","article-title":"Infliximab-induced systemic lupus erythematosus","volume":"137","author":"Ali Y","year":"2002","unstructured":"Ali Y, Shah S. Infliximab-induced systemic lupus erythematosus. Ann Intern Med. 2002, 137:625-6. 10.7326\/0003-4819-137-7-200210010-00030","journal-title":"Ann Intern Med"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1191\/0961203302lu236cr","article-title":"Drug-induced lupus following treatment with infliximab in rheumatoid arthritis","volume":"11","author":"Favalli EG","year":"2002","unstructured":"Favalli EG, Sinigaglia L, Varenna M, Arnoldi C. Drug-induced lupus following treatment with infliximab in rheumatoid arthritis. Lupus. 2002, 11:753-5. 10.1191\/0961203302lu236cr","journal-title":"Lupus"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-017-3884-2","article-title":"Diverse patterns of anti-TNF-\u03b1-induced lupus: case series and review of the literature","volume":"37","author":"Shovman O","year":"2018","unstructured":"Shovman O, Tamar S, Amital H, Watad A, Shoenfeld Y. Diverse patterns of anti-TNF-\u03b1-induced lupus: case series and review of the literature. Clin Rheumatol. 2018, 37:563-8. 10.1007\/s10067-017-3884-2","journal-title":"Clin Rheumatol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-011-2137-y","article-title":"Drug-induced lupus in anti-TNF-alpha therapy and its treatment with rituximab","volume":"32","author":"Diaz JC","year":"2012","unstructured":"Diaz JC, Vallejo S, Ca\u00f1as CA. Drug-induced lupus in anti-TNF-alpha therapy and its treatment with rituximab. Rheumatol Int. 2012, 32:3315-7. 10.1007\/s00296-011-2137-y","journal-title":"Rheumatol Int"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.081312","article-title":"Induction of systemic lupus erythematosus with tumor necrosis factor blockers","volume":"37","author":"Soforo E","year":"2010","unstructured":"Soforo E, Baumgartner M, Francis L, Allam F, Phillips PE, Perl A. Induction of systemic lupus erythematosus with tumor necrosis factor blockers. J Rheumatol. 2010, 37:204-5. 10.3899\/jrheum.081312","journal-title":"J Rheumatol"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1177\/0961203307080633","article-title":"Infliximab-induced SLE-like syndrome involving the lung and pleura","volume":"16","author":"Diri E","year":"2007","unstructured":"Diri E, Tello W, Ratnoff WD, Nugent K. Infliximab-induced SLE-like syndrome involving the lung and pleura. Lupus. 2007, 16:764-6. 10.1177\/0961203307080633","journal-title":"Lupus"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2007.08.003","article-title":"Drug-induced lupus due to anti-tumor necrosis factor alpha agents","volume":"37","author":"Costa MF","year":"2008","unstructured":"Costa MF, Said NR, Zimmermann B. Drug-induced lupus due to anti-tumor necrosis factor alpha agents. Semin Arthritis Rheum. 2008, 37:381-7. 10.1016\/j.semarthrit.2007.08.003","journal-title":"Semin Arthritis Rheum"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)07714-0","article-title":"Drug-induced systemic lupus erythematosus associated with etanercept therapy","volume":"359","author":"Shakoor N","year":"2002","unstructured":"Shakoor N, Michalska M, Harris CA, Block JA. Drug-induced systemic lupus erythematosus associated with etanercept therapy. Lancet. 2002, 359:579-80. 10.1016\/S0140-6736(02)07714-0","journal-title":"Lancet"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2008.09.008","article-title":"Autoimmune diseases induced by TNF-targeted therapies","volume":"22","author":"Ramos-Casals M","year":"2008","unstructured":"Ramos-Casals M, Brito-Zer\u00f3n P, Soto MJ, Cuadrado MJ, Khamashta MA. Autoimmune diseases induced by TNF-targeted therapies. Best Pract Res Clin Rheumatol. 2008, 22:847-61. 10.1016\/j.berh.2008.09.008","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.4065\/84.11.979","article-title":"Lupus-like syndrome attributable to anti-tumor necrosis factor alpha therapy in 14 patients during an 8-year period at Mayo Clinic","volume":"84","author":"Wetter DA","year":"2009","unstructured":"Wetter DA, Davis MD. Lupus-like syndrome attributable to anti-tumor necrosis factor alpha therapy in 14 patients during an 8-year period at Mayo Clinic. Mayo Clin Proc. 2009, 84:979-84. 10.4065\/84.11.979","journal-title":"Mayo Clin Proc"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1186\/ar1715","article-title":"Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey","volume":"7","author":"De Bandt M","year":"2005","unstructured":"De Bandt M, Sibilia J, Le Lo\u00ebt X, et al.. Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey. Arthritis Res Ther. 2005, 7:R545-51. 10.1186\/ar1715","journal-title":"Arthritis Res Ther"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2010.07.005","article-title":"Drug-induced lupus: an update","volume":"10","author":"Katz U","year":"2010","unstructured":"Katz U, Zandman-Goddard G. Drug-induced lupus: an update. Autoimmun Rev. 2010, 10:46-50. 10.1016\/j.autrev.2010.07.005","journal-title":"Autoimmun Rev"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200011)43:11<2383::AID-ANR2>3.0.CO;2-D","article-title":"Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials","volume":"43","author":"Charles PJ","year":"2000","unstructured":"Charles PJ, Smeenk RJ, De Jong J, Feldmann M, Maini RN. Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials. Arthritis Rheum. 2000, 43:2383-90. 10.1002\/1529-0131(200011)43:11&lt;2383::AID-ANR2&gt;3.0.CO;2-D","journal-title":"Arthritis Rheum"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2005.043166","article-title":"Safety analyses of adalimumab (HUMIRA) in global clinical trials and US postmarketing surveillance of patients with rheumatoid arthritis","volume":"65","author":"Schiff MH","year":"2006","unstructured":"Schiff MH, Burmester GR, Kent JD, Pangan AL, Kupper H, Fitzpatrick SB, Donovan C. Safety analyses of adalimumab (HUMIRA) in global clinical trials and US postmarketing surveillance of patients with rheumatoid arthritis. Ann Rheum Dis. 2006, 65:889-94. 10.1136\/ard.2005.043166","journal-title":"Ann Rheum Dis"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1177\/247553031218a00305","article-title":"Etanercept-induced lupus panniculitis with continued improvement after treatment with adalimumab for psoriatic arthritis","volume":"18a","author":"Chen TK","year":"2012","unstructured":"Chen TK, Haddican MM, Phelps RG, Spiera H. Etanercept-induced lupus panniculitis with continued improvement after treatment with adalimumab for psoriatic arthritis. Psoriasis Forum. 2012, 18a:142-6. 10.1177\/247553031218a00305","journal-title":"Psoriasis Forum"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/311044-clinical-characteristics-and-management-of-drug-induced-lupus-caused-by-tumor-necrosis-factor-inhibitors-a-comprehensive-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T09:31:27Z","timestamp":1730107887000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/311044-clinical-characteristics-and-management-of-drug-induced-lupus-caused-by-tumor-necrosis-factor-inhibitors-a-comprehensive-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,28]]},"references-count":64,"URL":"https:\/\/doi.org\/10.7759\/cureus.72522","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,28]]}}}